Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Long-term follow-up of people with chronic hepatitis B treated with AHB-137

Follows adults with chronic hepatitis B after AHB-137 injection treatment.

Plain-language title generated from the registry record
Registry title: Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

Key facts

Where
Beijing, Changchun, Changhou, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei, Kunming, Lanzhou, Liuzhou, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shenzhen, Taiyuan, Wuhan, Xi’an, Xiamen, Zhengzhou, Zhenjiang, and Zunyi, ChinaSee the 28 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic hepatitis B who were treated with AHB-137 in an earlier study and kept their response. They are followed to see how long the response lasts.

Age
18 years or older
Sex
All sexes
Disease stage
Chronic hepatitis B; had a complete or partial response in the earlier study and kept it until that study ended
Earlier treatment
Must have received at least one dose of AHB-137 in the earlier study, with no rescue medication

Main reasons for not taking part

  • Took part in another interventional clinical study since finishing AHB-137 treatment
  • Suspected cancer at screening
  • Any condition that needed hospital stay during this study
  • Any condition the investigator or Medical Monitor says rules out taking part

Read by machine on 12 November 2026.

Where in China

  • Beijing, Beijing MunicipalityHospital not named in the registryContact: LuNot yet recruiting
  • Changchun, JilinHospital not named in the registryContact: LuTaking people
  • Changhou, JiangsuHospital not named in the registryContact: LuTaking people
  • Changsha, HunanHospital not named in the registryContact: LuNot yet recruiting
  • Chengdu, SichuangHospital not named in the registryContact: LuNot yet recruiting
  • Chongqing, Chongqing MunicipalityHospital not named in the registryContact: LuTaking people
  • Foshan, GuangdongHospital not named in the registryContact: LuNot yet recruiting
  • Fuzhou, FujianHospital not named in the registryContact: LuTaking people
  • Guangzhou, GuangdongHospital not named in the registryContact: LuTaking people
  • Haikou, HainanHospital not named in the registryContact: LuNot yet recruiting
  • Hangzhou, ZhejiangHospital not named in the registryContact: LuTaking people
  • Hefei, AnhuiHospital not named in the registryContact: LuNot yet recruiting
  • Kunming, YunnanHospital not named in the registryContact: LuNot yet recruiting
  • Lanzhou, GansuHospital not named in the registryContact: LuNot yet recruiting
  • Liuzhou, GuangxiHospital not named in the registryContact: LuNot yet recruiting
  • Nanchang, JiangxiHospital not named in the registryContact: LuNot yet recruiting
  • Nanjing, JiangsuHospital not named in the registryContact: LuNot yet recruiting
  • Nanning, GuangxiHospital not named in the registryContact: LuNot yet recruiting
  • Shanghai, Shanghai MunicipalityHospital not named in the registryContact: LuNot yet recruiting
  • Shenyang, LiaoningHospital not named in the registryContact: LuNot yet recruiting
  • Shenzhen, GuangdongHospital not named in the registryContact: LuNot yet recruiting
  • Taiyuan, ShanxiHospital not named in the registryContact: LuNot yet recruiting
  • Wuhan, HubeiHospital not named in the registryContact: LuNot yet recruiting
  • Xi’an, ShanxiHospital not named in the registryContact: LuNot yet recruiting
  • Xiamen, FujianHospital not named in the registryContact: LuNot yet recruiting
  • Zhengzhou, HenanHospital not named in the registryContact: LuNot yet recruiting
  • Zhenjiang, JiangsuHospital not named in the registryContact: LuTaking people
  • Zunyi, GuizhouHospital not named in the registryContact: LuNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Ausper Biopharma Co., Ltd.
Trial code
NCT07146100
Record updated
18 August 2026
Original description
This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.Read full original descriptionShow less

Prospective, Open-label, Multicenter Long-term Follow-up Study to Evaluate the Durability of Virologic Response in Participants With Chronic Hepatitis B Previously Treated With AHB-137 Injection

This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.

Inclusion: Capable of giving informed consent; Participants who have previously received at least one dose of AHB-137 and achieved the complete of partial response in the parent study without rescue medication and who maintained response until the End of Study (EoS) visit in their parent study.

Exclusion: Participants who have/or are currently participating in another interventional clinical study since completing their treatment with AHB-137; Suspected for cancer at screening or any condition required hospitalization during this study , or any condition which, in the opinion of the investigator or Medical Monitor, contraindicates their participation in this study.

ClinicalTrials.gov NCT07146100